Use of the optimized sodium thiosulfate regimen for the treatment of calciphylaxis in Chinese patients.

Yang, Xin; Liu, Yuqiu; Xie, Xiaotong; Shi, Wen; Si, Jiyi; Li, Xiaomin; Zhang, Xiaoliang; Liu, Bicheng

Yang, Xin; Liu, Yuqiu; Xie, Xiaotong; Shi, Wen; Si, Jiyi; Li, Xiaomin; Zhang, Xiaoliang; Liu, Bicheng.

Afiliação

Yang X; Institute of Nephrology, Zhong Da Hospital, Southeast University, School of Medicine, Nanjing, China.
Liu Y; Institute of Nephrology, Zhong Da Hospital, Southeast University, School of Medicine, Nanjing, China.
Xie X; Institute of Nephrology, Zhong Da Hospital, Southeast University, School of Medicine, Nanjing, China.
Shi W; Institute of Nephrology, Zhong Da Hospital, Southeast University, School of Medicine, Nanjing, China.
Si J; Institute of Nephrology, Zhong Da Hospital, Southeast University, School of Medicine, Nanjing, China.
Li X; Institute of Nephrology, Zhong Da Hospital, Southeast University, School of Medicine, Nanjing, China.
Zhang X; Institute of Nephrology, Zhong Da Hospital, Southeast University, School of Medicine, Nanjing, China.
Liu B; Institute of Nephrology, Zhong Da Hospital, Southeast University, School of Medicine, Nanjing, China.

Ren Fail ; 44(1): 914-922, 2022 Dec.

Article em En | MEDLINE | ID: mdl-35634730

Assuntos

Calciofilaxia; Calciofilaxia/tratamento farmacológico; Calciofilaxia/etiologia; Quelantes/efeitos adversos; China; Humanos; Estudos Retrospectivos; Tiossulfatos

Palavras-chave

Sodium thiosulfate; calciphylaxis; clinical improvement; optimized STS regimen

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Calciofilaxia Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Ren Fail Assunto da revista: NEFROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google